ISTITUTO ONCOLOGICO VENETO
🇮🇹Italy
Clinical Trials
52
Active:17
Completed:16
Trial Phases
4 Phases
Phase 1:7
Phase 2:7
Phase 3:3
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (28 trials with phase data)• Click on a phase to view related trials
Not Applicable
11 (39.3%)Phase 1
7 (25.0%)Phase 2
7 (25.0%)Phase 3
3 (10.7%)Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients
Not Applicable
Not yet recruiting
- Conditions
- GlioblastomaIDH Wild-type and STAT3-positive Glioblastoma
- First Posted Date
- 2025-05-09
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Istituto Oncologico Veneto IRCCS
- Target Recruit Count
- 110
- Registration Number
- NCT06964815
- Locations
- 🇮🇹
IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, BO, Italy
🇮🇹IRST Dino Amadori, Meldola, FC, Italy
🇮🇹Azienda Ospedaliero Universitaria Policlinico "G. Rodolico - San Marco ", Catania, Italia/Catania, Italy
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Recruiting
- Conditions
- Prostate CancerBladder CancerKidney Cancer
- First Posted Date
- 2025-05-02
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Istituto Oncologico Veneto IRCCS
- Target Recruit Count
- 120
- Registration Number
- NCT06955910
- Locations
- 🇮🇹
Istituto Oncologico Veneto, Padova, Italy/Padova, Italy
Preventive Application of Single-use Negative Pressure Wound Therapy (sNPWT) in the Postoperative Course of Radiotreatated Limb Sarcoma Surgery
Not Applicable
Not yet recruiting
- Conditions
- SarcomaSarcoma,Soft Tissue
- First Posted Date
- 2025-04-23
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Istituto Oncologico Veneto IRCCS
- Target Recruit Count
- 48
- Registration Number
- NCT06941194
- Locations
- 🇮🇹
Istituto Oncologico Veneto, Padova, Italy/Padova, Italy
Scarless Advanced Breast Extended Oncoplasty: The ScarABEO Study
Recruiting
- Conditions
- Breast CancerOncoplastic Breast SurgeryChest Wall Perforator FlapOncoplastic Breast-conserving Surgery
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Istituto Oncologico Veneto IRCCS
- Target Recruit Count
- 250
- Registration Number
- NCT06906237
- Locations
- 🇮🇹
Veneto Institute of Oncology, Padova, Italy
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
Not Applicable
Recruiting
- Conditions
- Primary Visceral Tumors of Any HistotypeVisceral LesionsLiver CancerLiver Metastasis Colon CancerMelanomaPrimary Pancreatic TumorRetroperitoneal SarcomaAbdominal and/or Peritoneal LocalizationsMerkel Cell CarcinomaSquamous Cell Carcinoma
- First Posted Date
- 2024-12-31
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- Istituto Oncologico Veneto IRCCS
- Target Recruit Count
- 24
- Registration Number
- NCT06753136
- Locations
- 🇮🇹
Istituto Oncologico Veneto, Padova, Italy
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
News
No news found